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1,2 Therefore, it is requisite to explore a novel strategy against ageing. Factors contributing to stem cell ageing are classified as systemic and micro-environment including hormones, systemic inflammation, host microbiome, local immune system and niche structure. Emerging studies suggest a close relationship between diversity, a constituent of host microbiota with the ageing process and ageing-related diseases. For instance, skeletal mass, bone formation and bone growth are progressively declined with age, while modulation of gut microbiota by administration of antibiotics treatments in conventional mice or administration of specific-gut microbiota in germ-free mice results in a decrease and an increase bone mass and bone growth respectively. The molecular events underlying are commensal bacteria secreted short-chain fatty acids to regulate the hormone for skeletal growth namely insulin-like growth factor-1. 3 Another study also mentioned that disruption of microbiota interferes our normal circadian clock, consequently provoking metabolic disorders accompanied by exaggerating the ageing. 4, 5 In mammals, the change in diversity of gut microbiota has been linked to the different age groups. In general, elderly peoples result less Bacteroidetes in terms of quantity and quality and more
Firmicutes compared with healthy middle-aged people In southwest China cohort. 6 In experimental models, host microbiota has associated with the lifespan of Drosophila. Studies demonstrated that modulation of gut microbiota in drosophila by antibiotic treatment or stool transplantation from old Drosophila to young Drosophila increases or decreases the lifespan of Dorosphila respectively. 7 However, how host microbiota affects the stem cell functions in term of ageing is still vague.
In this Review, we describe the contributions of host microbiota in stem cell ageing through modulation of metabolism, epigenetic changes as well as the inflammatory responses by the host immune system. We also introduce the possible microbiota-mediated signalling pathways in stem cell ageing. Another type of microbial metabolites is endogenous ethanol.
Bacterially derived ethanol is produced by Proteobacteria including
Escherichia coli and other Enterobacteriaceae. 23 The elevated endogenous ethanol causes the inhibitory effects on proliferating stem cells and depletion of stem and progenitor cells in the human hippocampus. 24 Besides, more ethanol accumulates in the gut resulting in the increase of gut permeability by disruption of epithelial tight junctions especially zone occludins. 25 This allows the translocation of pathogenic bacteria and its endotoxins and ethanol exert more directly destructive effects on tissues. 25 As a consequence, depletion of stem cells pool occurs in order to compensate the damage tissues and accelerating ageing.
In Drosophila, the host microbiota also regulates the self-renewal 
| Host microbiome and epigenetic alterations in stem cell ageing
A growing body of evidence showed that modulation of global DNA methylation has been linked to ageing in various stem cells such as HSCs and other tissues. 30, 31 Besides, muscle and haematopoietic stem cells exhibit the enhancement of histone repressive marks, such as histone H3 lysine 9 trimethylation (H3K9me3) and histone H3 lysine 27 trimethylation (H3K27me3) during the ageing process. 32 Microbiota may exacerbate the ageing process by releasing more their metabolites butyrate in guts. Butyrate has known as an enhancer for H3K27me3 in vivo model. 33 The possible underlying mechanism for enhanced H3K27me3-modulated epigenetic modulation is increasing H3K27me3-producing enzymes polycomb repressive complexes 2, subsequently facilitating the loss in epigenetic marking as well as drift of H3K27me3, diminishing the genes in glycolysis along with a decline of energy and NADH to NAD + ratio, thereby the stem cells become more susceptible to ROS and propel itself from quiescent state into an active state for differentiation and proliferation. 34 Consistently, repressing the H327Kme3 in both C elegans and D melanogaster exhibited anti-ageing effects. 35, 36 Apart from histone modulation in gene expressions, microbiota Moreover, another enhanced transcriptional factor IRFs has been reported in promoting senescence and impairing self-renewal and differentiation of stem cells and consequently shorting lifespan in vivo. 40 In an opposite way, depletion of microbiota reduces the relative methylation level of certain genes such as the toll-like receptor 4 gene, which is a gene associated with chronic inflammation in ageing. 41 Besides the responses of age-associated genes STAT and IRFs are diminished in antibiotic-treated mice. 42 Collectively, microbiota involves in the regulation of age-related gene expressions through facilitating transcription factors in the development of stem cells. 64 In the bone, both IL-6, IL-10 and TNF-α have shown a positively associated with the differentiation of bone marrow stem cells. 65 In the skin grafts, IL-17
promotes the self-renewal and differentiation of mesenchymal stem cells. 66 In line with this hypothesis, alterations in gut microbiota attenuate the systemic and hepatic inflammation in obese and diabetic mice by restoring endogenous intestinotrophic proglucagon-derived peptide-dependent modulations of the gut permeability. 67 Collectively, reconstruction of gut microbiota through the administration of probiotics restores the balance of microbiome in guts and ameliorates the gut permeability and preventing pathological activation of immune responses and its driven abnormal differentiation of stem cells in the recovery of hepatic functions. 68 However, most of the publications for immune system-mediated stem cell proliferation are under the condition from injury or diseases caused cell regeneration by stem cell. The effects of microbiota in normal conditions are poorly understood and require further investigations.
| Host microbiome and ageing-associated developmental pathway
Host microbiome leads ageing-associated development on stem cells through several pathways including Wnt, Notch, transforming growth factor beta(TGF-β), mitogen-activated protein kinases (p38-MAPK) and JUN N-terminal kinase(JNK) signalling pathways. reporter activity by its HDAC inhibitor characteristic. 71 As shown in Table 1 
| Wnt signalling pathway

| p38-MAPK signalling pathway
Ageing associated activation of p38-MAPK and suppression of 
| CON CLUS I ON S AND FUTURE PER S PEC TIVE S
The role of stem cells in ageing is repairing damaged tissues and regenerate specific tissues in order to maintain tissues homoeostasis. Reconstruction of gut microbiota and in turn restoring gut permeability is a crucial strategy in dealing with the stem cell-associated ageing process. To date, faecal microbiota transplantation brings our attention to the reconstruction of gut microbiota. There is evidence that faecal microbiota transplantation improves the growth performance by reducing intestinal permeability in piglets and maintaining intestinal morphology. 99 Since increasing intestinal permeability has been known in ageing-associated diseases, restoring intestinal permeability by faecal microbiota transplantation may be an effective and regenerative medicine strategy in stem cell development for aged. However, it remains to be investigated whether fecal microbiota transplantation from young donors to old receivers restores the self-renewal, differentiation and regenerative capacity of stem cells in order to ameliorate the health span. In conclusion, more investigations in the cross-talk between microbiota and intestinal stem cells are required to pave the way for the development of therapeutic drugs in prolonging lifespan and tackling ageing-associated diseases.
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